Ampio Pharmaceuticals, Inc. (AMEX:AMPE) went up by 2.52% from its latest closing price when compared to the 1-year high value of $1.24 and move down -77.14%, while AMPE stocks collected 2.42% of gains with the last five trading sessions. Press Release reported on 08/19/20 that Ampio Provides Update on COVID-19 Clinical Trial Activities
Ampio Pharmaceuticals, Inc. (AMEX:AMPE) Worth an Investment?
Ampio Pharmaceuticals, Inc. (AMEX: AMPE) The 36 Months beta value for AMPE stocks is at 1.84, while 1 of the analysts out of 1 who provided ratings for Ampio Pharmaceuticals, Inc. stocks as a “buy” while 0 as overweight, 0 rated it as hold and 0 as sell. The average price we get from analysts is $4.00 which is -$0.7 below current price. AMPE currently has a short float of 9.46% and public float of 162.49M with average trading volume of 3.40M shares.
AMPE Market Performance
AMPE stocks went up by 2.42% for the week, with the monthly drop of -36.68% and a quarterly performance of 41.87%, while its annual performance rate touched 42.50%. The simple moving average for the period of the last 20 days is -12.77% for AMPE stocks with the simple moving average of 15.34% for the last 200 days.
Analysts’ Opinion on Ampio Pharmaceuticals, Inc. (AMEX:AMPE)
Many brokerage firms have already submitted their reports for AMPE stocks, with ROTH Capital repeating the rating for AMPE shares by setting it to “Buy”. The predicted price for AMPE socks in the upcoming period according to ROTH Capital is $4 based on the research report published on December 19, 2019.
Aegis Capital, on the other hand, stated in their research note that they expect to see AMPE stock at the price of $16, previously predicting the value of $15. The rating they have provided for AMPE stocks is “Buy” according to the report published on March 17, 2014.
Aegis Capital gave “Buy” rating to AMPE stocks, setting the target price at $11 in the report published on September 25, 2012.
AMPE Stocks -11.05% Far from 50 Day Moving Average
After a stumble in the market that brought AMPE to its low price for the period of the last 52 weeks, Ampio Pharmaceuticals, Inc. was unable to take a rebound, for now settling with -43.32% of loss for the given period.
The stock volatility was left at 9.40%, however, within the period of a single month, the volatility rate increased by 8.62%, while the shares sank at the distance of -34.93% for the moving average in the last 20 days. In oppose to the moving average for the last 50 days, trading by +22.35% upper at the present time.
In the course of the last 5 trading sessions, AMPE went up by +2.42%, which changed the moving average for the period of 200 days to the total of +76.36% of gains for the stock in comparison to the 20-day moving average settled at $0.7868. In addition, Ampio Pharmaceuticals, Inc. saw 20.55% in overturn over the period of a single year with a tendency to cut further gains.
AMPE Stock Fundamentals
Based on Ampio Pharmaceuticals, Inc. (AMPE), the company’s capital structure generated 22.80 points for debt to equity in total, while total debt to capital is set at the value of 18.57.